ArticleJournal for immunotherapy of cancer2024

Safety and efficacy of SNK01 (autologous natural killer cells) in combination with cytotoxic chemotherapy and/or cetuximab after failure of prior tyrosine kinase inhibitor in non-small cell lung cancer: non-clinical mouse model and phase I/IIa clinical study.

Myeong Geun Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.